FFM

Fairmount Funds Management Portfolio holdings

AUM $772M
1-Year Est. Return 35.05%
This Quarter Est. Return
1 Year Est. Return
+35.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.23B
AUM Growth
+$348M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
17
New
Increased
Reduced
Closed

Top Buys

1
+$78.7M
2
+$43.2M
3
+$36.4M
4
BCAX
Bicara Therapeutics
BCAX
+$32.7M
5
ZBIO
Zenas BioPharma
ZBIO
+$32M

Top Sells

1
+$32.3M
2
+$24.3M
3
+$21.4M
4
TERN icon
Terns Pharmaceuticals
TERN
+$5.1M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$1.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$212M 17.2%
2,360,077
2
$173M 13.99%
1,687,064
-237,562
3
$120M 9.76%
2,048,647
4
$118M 9.58%
4,018,101
5
$81.8M 6.63%
3,202,798
6
$80.1M 6.49%
3,204,841
7
$78.7M 6.38%
+3,211,922
8
$78.4M 6.36%
3,445,813
+1,600,000
9
$73.9M 6%
2,700,691
-62,146
10
$67.2M 5.45%
6,225,641
11
$43.2M 3.51%
+3,103,448
12
$39.1M 3.17%
3,554,129
13
$32.7M 2.65%
+1,284,169
14
$32M 2.6%
+1,892,806
15
$2.8M 0.23%
123,538
-945,661
16
– –
-931,890
17
– –
-748,996